[2-(Me2NCH2)C6H4]SnCl3 (1) was prepared via (i) salt elimination reaction between RLi and SnCl4 (1:1 molar ratio), in toluene solution, and (ii) redistribution reaction between [2-(Me2NCH2)C6H4]4Sn and SnCl4 (1:3 molar ratio), in the absence of a solvent. Recrystallization from DMSO afforded the isolation of the DMSO adduct [2-(Me2NCH2)C6H4]SnCl3·DMSO (1a). The compounds were characterized by multinuclear NMR (1H, 13C, 119Sn) in solution. The molecular structures of 1 and 1a were determined by single-crystal X-ray diffraction. The crystal structure of compounds 1 and 1a consists of discrete monomeric molecular units separated by normal van der Waals distances between heavy atoms. The N atom of the pendant CH2NMe2 arm is strongly coordinated to the tin atom, thus resulting in distorted trigonal bipyramidal (C,N)SnCl3 and octahedral (C,N)SnCl3O cores for 1 and 1a, respectively. For both compounds hydrogen bonding generates supramolecular associations in crystal.
No takes yet. Share an insight, caveat, or question.
Varga et al. (2005) studied this question.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: